Skip to content

Drug interactions

Bosentan + Netupitant-palonosetron

Severity: Moderate

Bosentan and Netupitant-palonosetron: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan induces CYP3A4 and may reduce netupitant concentrations, weakening protection against chemotherapy-induced nausea and vomiting. The induction is moderate rather than strong.

What this interaction means in plain words

Bosentan and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

CYP3A4 induction by bosentan increases netupitant clearance.

What to do

Monitor for breakthrough nausea and vomiting and add rescue antiemetics as needed. Consider an alternative regimen if control is inadequate.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Netupitant-palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Netupitant-palonosetron?

MediHelp rates the interaction as moderate. Bosentan and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bosentan induces CYP3A4 and may reduce netupitant concentrations, weakening protection against chemotherapy-induced nausea and vomiting. The induction is moderate rather than strong.

How serious is the interaction between Bosentan and Netupitant-palonosetron?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for breakthrough nausea and vomiting and add rescue antiemetics as needed. Consider an alternative regimen if control is inadequate.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in